Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23126375
Abstract: Human epidermal growth factor receptor-2 (HER2) is overexpressed in up to 30% of breast cancer cases, causing a more aggressive tumour growth and poor prognosis. Trastuzumab, the humanized antibody targeted to HER2, increased the life…
read more here.
Keywords:
ser368;
doxorubicin sequential;
trastuzumab doxorubicin;
sequential administration ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Pathogens"
DOI: 10.3390/pathogens12050655
Abstract: In the past few years, the continuous pandemic of COVID-19 caused by SARS-CoV-2 has placed a huge burden on public health. In order to effectively deal with the emergence of new SARS-CoV-2 variants, it becomes…
read more here.
Keywords:
omicron strain;
previously unexposed;
immune responses;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Oncology Letters"
DOI: 10.3892/ol.2023.13874
Abstract: Severe drug-induced lung injury (DLI) has been reported to be associated with sequential administration of osimertinib, a third-generation tyrosine kinase inhibitor, following a programmed cell death ligand 1 (PD-L1) inhibitor. However, the relationship of sequential…
read more here.
Keywords:
inhibitor;
group;
patients received;
administration inhibitor ... See more keywords